The CpG Island Methylator Phenotype in Breast Cancer is Associated with the Lobular Subtype

References

• Ferlay J , Steliarova-FoucherE , Lortet-TieulentJet al. Cancer incidence and mortality patterns in Europe, estimates for 40 countries in 2012 . Eur. J. Cancer49 ( 6 ), 1374 – 1403 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Arps DP , HealyP , ZhaoL , KleerCG , PangJC . Invasive ductal carcinoma with lobular features, a comparison study to invasive ductal and invasive lobular carcinomas of the breast . Breast Cancer Res. Treat.138 ( 3 ), 719 – 726 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Li C , UribeD , DalingJ . Clinical characteristics of different histologic types of breast cancer . Br. J. Cancer93 ( 9 ), 1046 – 1052 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Yerushalmi R , HayesM , GelmonK . Breast carcinoma – rare types, review of the literature . Ann. Oncol.20 ( 11 ), 1763 – 1770 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• G Group ABCS . Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases . Br. J. Cancer83 ( 10 ), 1301 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Loman N , JohannssonO , KristofferssonU , OlssonH , BorgÅ . Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer . J. Natl Cancer Inst.93 ( 16 ), 1215 – 1223 ( 2001 ).
   PubMedGoogle Scholar
• Shih HA , CouchFJ , NathansonKLet al. BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic . J. Clin. Oncol.20 ( 4 ), 994 – 999 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Laird PW . The power and the promise of DNA methylation markers . Nat. Rev. Cancer3 ( 4 ), 253 – 266 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Hill VK , RickettsC , BiecheIet al. Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity . Cancer Res.71 ( 8 ), 2988 – 2999 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Fang F , TurcanS , RimnerAet al. Breast cancer methylomes establish an epigenomic foundation for metastasis . Sci. Transl. Med.3 ( 75 ), 75ra25 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Fackler MJ , UmbrichtCB , WilliamsDet al. Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence . Cancer Res.71 ( 19 ), 6195 – 6207 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Holm K , HegardtC , StaafJet al. Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns . Breast Cancer Res.12 ( 3 ), R36 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Kamalakaran S , VaradanV , Giercksky RussnesHEet al. DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables . Mol. Oncol.5 ( 1 ), 77 – 92 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Network CGA . Comprehensive molecular portraits of human breast tumours . Nature490 ( 7418 ), 61 – 70 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Hughes LA , Khalid-de BakkerCA , SmitsKMet al. The CpG island methylator phenotype in colorectal cancer: progress and problems . Biochim. Biophys. Acta1825 ( 1 ), 77 – 85 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Toyota M , AhujaN , Ohe-ToyotaM , HermanJG , BaylinSB , IssaJ-PJ . CpG island methylator phenotype in colorectal cancer . Proc. Natl Acad. Sci. USA96 ( 15 ), 8681 – 8686 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Hughes LA , MelotteV , De SchrijverJet al. The CpG island methylator phenotype, what’s in a name? Cancer Res. 73 ( 19 ), 5858 – 5868 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Van der Auwera I , YuW , SuoL , Van NesteLet al. Array-based DNA methylation profiling for breast cancer subtype discrimination . PLoS ONE5 ( 9 ), e12616 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Turcan S , RohleD , GoenkaAet al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype . Nature483 ( 7390 ), 479 – 483 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Noushmehr H , WeisenbergerDJ , DiefesKet al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma . Cancer cell17 ( 5 ), 510 – 522 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Figueroa ME , Abdel-WahabO , LuCet al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation . Cancer Cell18 ( 6 ), 553 – 567 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Pansuriya TC , van EijkR , d’ AdamoPet al. Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome . Nat. Genet.43 ( 12 ), 1256 – 1261 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Bibikova M , BarnesB , TsanCet al. High density DNA methylation array with single CpG site resolution . Genomics98 ( 4 ), 288 – 295 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Christgen M , BruchhardtH , HadamitzkyCet al. Comprehensive genetic and functional characterization of IPH-926, a novel CDH1-null tumour cell line from human lobular breast cancer . J. Pathol.217 ( 5 ), 620 – 632 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Whitehead RH , BertoncelloI , WebberLM , PedersenJS . A new human breast carcinoma cell line (PMC42) with stem cell characteristics. I. Morphologic characterization . J. Natl Cancer Inst.70 ( 4 ), 649 – 661 ( 1983 ).
   PubMedGoogle Scholar
• Ackland M , MichalczykA , WhiteheadR . PMC42, a novel model for the differentiated human breast . Exp. Cell Res.263 ( 1 ), 14 – 22 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Roessler J , AmmerpohlO , GutweinJet al. Quantitative cross-validation and content analysis of the 450k DNA methylation array from Illumina, Inc. BMC Res. Notes 5 ( 1 ), 210 ( 2012 ).
   PubMedGoogle Scholar
• Kilaru V , BarfieldRT , SchroederJW , SmithAK , ConneelyKN . MethLAB, a graphical user interface package for the analysis of array-based DNA methylation data . Epigenetics7 ( 3 ), 225 – 229 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Wang D , YanL , HuQet al. IMA, an R package for high-throughput analysis of Illumina’s 450K Infinium methylation data . Bioinformatics28 ( 5 ), 729 – 730 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Benjamini Y , HochbergY . Controlling the false discovery rate, a practical and powerful approach to multiple testing . J. R. Stat. Soc. Series B Stat. Methodol.57 ( 1 ), 289 – 300 ( 1995 ).
   Web of Science ®Google Scholar
• Lehmann U , HasemeierB , ChristgenMet al. Epigenetic inactivation of microRNA gene hsa-mir-9–1 in human breast cancer . J. Pathol.214 ( 1 ), 17 – 24 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Kaplan Meier-plotter [cancer survival analysis] . http://kmplot.com
   Google Scholar
• Györffy B , LanczkyA , EklundACet al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients . Breast Cancer Res. Treat.123 ( 3 ), 725 – 731 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Coppersmith D , HongSJ , HoskingJR . Partitioning nominal attributes in decision trees . Data Min. Knowl. Discov.3 ( 2 ), 197 – 217 ( 1999 ).
   Web of Science ®Google Scholar
• Rauch T , LiH , WuX , PfeiferGP . MIRA-assisted microarray analysis, a new technology for the determination of DNA methylation patterns, identifies frequent methylation of homeodomain-containing genes in lung cancer cells . Cancer Res.66 ( 16 ), 7939 – 7947 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Bae YK , BrownA , GarrettEet al. Hypermethylation in histologically distinct classes of breast cancer . Clin. Cancer Res.10 ( 18 ), 5998 – 6005 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Krop I , MaguireP , Lahti-DomeniciJet al. Lack of HIN-1 methylation in BRCA1-linked and ‘BRCA1-like’ breast tumors . Cancer Res.63 ( 9 ), 2024 – 2027 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Fackler MJ , McVeighM , EvronEet al. DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma . Int. J. Cancer107 ( 6 ), 970 – 975 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Lehmann U , CelikkayaG , HasemeierB , LängerF , KreipeH . Promoter hypermethylation of the death-associated protein kinase gene in breast cancer is associated with the invasive lobular subtype . Cancer Res.62 ( 22 ), 6634 – 6638 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Bediaga NG , Acha-SagredoA , GuerraIet al. DNA methylation epigenotypes in breast cancer molecular subtypes . Breast Cancer Res.12 ( 5 ), R77 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Waddell N , ArnoldJ , CocciardiSet al. Subtypes of familial breast tumours revealed by expression and copy number profiling . Breast Cancer Res. Treat.123 ( 3 ), 661 – 677 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Jönsson G , NaylorTL , Vallon-ChristerssonJet al. Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization . Cancer Res.65 ( 17 ), 7612 – 7621 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Bertucci F , OrsettiB , NègreVet al. Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles . Oncogene27 ( 40 ), 5359 – 5372 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Huiping C , SigurgeirsdottirJ , JonassonJet al. Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer . Br. J. Cancer81 ( 7 ), 1103 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Shen C-Y , YuJ-C , LoY-Let al. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma, an implication for mutator phenotype and breast cancer pathogenesis . Cancer Res.60 ( 14 ), 3884 – 3892 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Horlings HM , WeigeltB , AndersonEMet al. Genomic profiling of histological special types of breast cancer . Breast Cancer Res. Treat.142 ( 2 ), 257 – 269 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Wessels LF , van WelsemT , HartAA , van’t VeerLJ , ReindersMJ , NederlofPM . Molecular classification of breast carcinomas by comparative genomic hybridization a specific somatic genetic profile for BRCA1 tumors . Cancer Res.62 ( 23 ), 7110 – 7117 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Nishizaki T , ChewK , ChuLet al. Genetic alterations in lobular breast cancer by comparative genomic hybridization . Int. J. Cancer74 ( 5 ), 513 – 517 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Kozlowska J , KarpinskiP , SzmidaEet al. Assessment of chromosomal imbalances in CIMP-high and CIMP-low/CIMP-0 colorectal cancers . Tumour Biol.33 ( 4 ), 1015 – 1019 ( 2012 ).
   PubMedGoogle Scholar
• Fleischer T , FrigessiA , JohnsonKCet al. Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis . Genome Biol.15 , 435 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Inokawa Y , NomotoS , HishidaMet al. Dynamin 3, a new candidate tumor suppressor gene in hepatocellular carcinoma detected by triple combination array analysis . Onco. Targets Ther.6 , 1417 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Dedeurwaerder S , DesmedtC , CalonneEet al. DNA methylation profiling reveals a predominant immune component in breast cancers . EMBO Mol. Med.3 ( 12 ), 726 – 741 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Ghayad SE , VendrellJA , BiecheIet al. Identification of TACC1, NOV, and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancer . J. Mol. Endocrinol.42 ( 2 ), 87 – 103 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Conte N , Charafe-JauffretE , DelavalBet al. Carcinogenesis and translational controls, TACC1 is down-regulated in human cancers and associates with mRNA regulators . Oncogene21 ( 36 ), 5619 – 30 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Ha G-H , KimJ-L , BreuerE-KY . Transforming acidic coiled-coil proteins (TACCs) in human cancer . Cancer Lett.336 ( 1 ), 24 – 33 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Petrova DT , AsifAR , ArmstrongVWet al. Expression of chloride intracellular channel protein 1 (CLIC1) and tumor protein D52 (TPD52) as potential biomarkers for colorectal cancer . Clin. Biochem.41 ( 14 ), 1224 – 1236 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Hagiwara K , ItoH , MurateT , MiyataY , OhashiH , NagaiH . PROX1 overexpression inhibits protein kinase C beta II transcription through promoter DNA methylation . Genes Chromosomes Cancer51 ( 11 ), 1024 – 1036 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Yu X , SongH , XiaTet al. Growth inhibitory effects of three miR-129 family members on gastric cancer . Gene532 ( 1 ), 87 – 93 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Kang M , LiY , LiuWet al. miR-129–122 suppresses proliferation and migration of esophageal carcinoma cells through downregulation of SOX4 expression . Int. J. Mol. Med.32 ( 1 ), 51 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Chen X , ZhangL , ZhangTet al. Methylation-mediated repression of microRNA 129–122 enhances oncogenic SOX4 expression in HCC . Liver Int.33 ( 3 ), 476 – 486 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Wong K-Y , YimRL-H , KwongY-Let al. Epigenetic inactivation of the MIR129–2 in hematological malignancies . J. Hematol. Oncol.6 ( 1 ), 16 ( 2013 ).
   PubMedGoogle Scholar
• Anwar SL , AlbatC , KrechTet al. Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker . Int. J. Cancer133 ( 3 ), 660 – 670 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lu C-Y , LinK-Y , TienM-T , WuC-T , UenY-H , TsengT-L . Frequent DNA methylation of MiR-129–122 and its potential clinical implication in hepatocellular carcinoma . Genes Chromosomes Cancer52 ( 7 ), 636 – 643 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Chen X , HuH , GuanXet al. CpG island methylation status of miRNAs in esophageal squamous cell carcinoma . Int. J. Cancer130 ( 7 ), 1607 – 1613 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Huang Y-W , LiuJC , DeatherageDEet al. Epigenetic repression of microRNA-129–122 leads to overexpression of SOX4 oncogene in endometrial cancer . Cancer Res.69 ( 23 ), 9038 – 9046 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Tsai K-W , WuC-W , HuL-Yet al. Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer . Int. J. Cancer129 ( 11 ), 2600 – 2610 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Takagi D , TatsumiY , YokochiTet al. Novel adaptor protein Shf interacts with ALK receptor and negatively regulates its downstream signals in neuroblastoma . Cancer Sci.104 ( 5 ), 563 – 572 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Ricketts CJ , MorrisMR , GentleDet al. Methylation profiling and evaluation of demethylating therapy in renal cell carcinoma . Clin. Epigenetics5 ( 1 ), 16 ( 2013 ).
   PubMedGoogle Scholar